ArticleScientific reports2026
Copper isotope fractionation and copper-to-zinc ratios reveal altered metal homeostasis in prostate cancer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Trace metal homeostasis is increasingly recognized as a reflection of cellular metabolism and redox balance. This study applies high-precision copper isotope and elemental ratio analysis to human serum to investigate how prostate cancer alters systemic metal regulation. Using multi-collector inductively coupled plasma mass spectrometry (MC-ICP-MS) adapted from geochemical applications, we quantified copper isotope fractionation and Cu/Zn ratios across disease stages. Patients with localized or newly metastatic prostate cancer exhibited isotopically heavier serum copper compared to healthy controls, while advanced, castration-resistant disease showed higher copper concentrations, lower zinc levels, and elevated Cu/Zn ratios. Together, these findings suggest that prostate cancer-associated alterations in copper and zinc homeostasis may reflect modulation by sex steroid-dependent physiological states. They also demonstrate the sensitivity of MC-ICP-MS in detecting subtle isotopic shifts in biological samples and establish its value as a tool for characterizing metabolic and redox alterations in prostate cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.